A. Kakarieka

发表

Clinical significance of the finding of subarachnoid blood on CT scan after head injury

R. Braakman, A. Kakarieka, E. H. Schakel, 2005, Acta Neurochirurgica.

Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys

Paul W Smith, M. Stoeckli, P. Couttet, 2019, Front. Immunol..

Review on traumatic subarachnoid hemorrhage.

A. Kakarieka, Aigirdas Kakarieka, 1997, Neurological research.

Traumatic intracerebral lesions without extracerebral haematoma in 218 patients

G. Edner, T. Mathiesen, A. Kakarieka, 2005, Acta Neurochirurgica.

Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis - results of the placebo-controlled, double-blind, Phase III ORATORIO study

D. Arnold, X. Montalban, A. Bar-Or, 2015 .

Ofatumumab versus Teriflunomide in Multiple Sclerosis.

Jeffrey A. Cohen, X. Montalban, L. Kappos, 2020, The New England journal of medicine.

Demographic and Clinical Aspects of tSAH

A. Kakarieka, 1997 .

Analysis of CT Findings in tSAH

A. Kakarieka, 1997 .

Traumatic subarachnoid hemorrhage and its treatment with nimodipine. German tSAH Study Group.

A. Harders, R. Braakman, A. Kakarieka, 1996, Journal of neurosurgery.

Subarachnoid Haemorrhage after Head Injury

R. Braakman, A. Kakarieka, E. H. Schakel, 1995 .

Clinical experiences with nimodipine in cerebral ischemia.

A. Kakarieka, E. H. Schakel, J. Fritze, 1994, Journal of neural transmission. Supplementum.

Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

R. Hauser, G. Abbruzzese, M. Panisset, 2009, Movement disorders : official journal of the Movement Disorder Society.